Medpace Holdings, Inc. (1MEDP)
MTA
523.80
-4.80 (-0.91%)
Closed
Aug 25, 2026
Day's Range
523.80531.00
52 wk Range
327.60554.20
Financial Statements - 1MEDP - Medpace Holdings, Inc.
Revenue
2.53B▲ 41.8%
Net Income
451.12M▲ 31.8%Net Margin 17.8%
EBITDA
570.79M▲ 41.5%
Free Cash Flow
681.86M▲ 40.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 2.53B | 1.78B |
| Cost of Goods | 1.76B | 1.22B |
| Gross Profit | 760.61M | 555.31M |
 Operating Expense | - | - |
| Operating Income | 534.93M | 378.10M |
| Non-Operating Interest | - | - |
| Other Income Expense | -5.33M | 3.43M |
| Pre Tax Income | 542.37M | 402.68M |
| Income Tax | 91.25M | 60.52M |
| Net Income | 451.12M | 342.15M |
| EPS Basic | 15.64 | 13.06 |
| EPS Diluted | 15.28 | 12.63 |
| Basic Shares Outstanding | 28.84M | 26.19M |
| Diluted Shares Outstanding | 28.84M | 26.19M |
| Ebit | 534.93M | 378.10M |
| Ebitda | 570.79M | 403.27M |
| Net Income Continuous Operations | 451.12M | 342.15M |
| Minority Interests | - | - |
| Preferred Stock Dividends | 0 | 37.22K |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
